维普中文期刊产品整合服务
37篇 您的检索式:作者名="FCCP"
    题名 作者 年代 出处 被引量
1The year in Cardiothoracic and Vascular Anesthesia:Selected Highlights From 2009显示文摘Harish Ramakrishna, MD, FASE Jens Fassl, MD Ashish Sinha, MD Prakash Patel, MD Hynek Riha, MD, DEAA, FCCP Michael Andritsos, MD Insung Chung,MD John G.T. Augoustides, MD, FASE, FAHA 2010麻醉与监护论坛2010,17,3:2
2Treatment of COPD with cilomilast 显示文摘Stephen I Fccp R Schaehter N 2006Chest2006,129,:1
3Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction显示文摘RODOLFO C MORICE FCCP TURHAN ECE 2001Chest2001,119,:1
4COPD in Perspective显示文摘Thomas L Petty M D Master FCCP 2002Chest2002,121,5:1
5Update of antithrombotic guidelines: Medical professionalism and the funnel of knowledge 显示文摘HEFFNER J E FCCP M D 2016Chest2016,149,2:1
6Therapeutic hypotherrnia : past, pres- ent, and future 显示文摘Joseph V FCCP Pilar A 2008Chest2008,133,5:1
7Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy显示文摘Edmond Chaileux Jean-PIERRE laaban FCCP and Dan Veale 2003Chest2003,123,:1
8长期应用大环内酯类抗生素治疗气道炎症性疾病显示文摘Adam L.Friedlander MD Richard K.Albert MD FCCP CHEST中文版0,,02:1
9Obstructive Sleep Apnea and Cardiovascular Disease in Women显示文摘Obstructive Sleep Apnea(OSA)is a common chronic disorder that affects 5–10%of the US population with a higher prevalence in men compared to women by 2:1 in population studies.By contrast,in patients with cardiovascular disease,its prevalence can exceed 50%depending on the specifi c disorder surveyed.Although sex differences have been well described for cardiovascular risk factors;existing data regarding the impact of sex on the relationship between OSA and cardiovascular outcomes is controversial.Similarly,while there is strong evidence for increased prevalence of cardiovascular conditions,such as systemic hypertension,atrial fibrillation,as well as heart failure amongst patients suffering from OSA;confl icting evidence exists regarding the incidence and bidirectional relationship between them as well as the impact of treatment of OSA on cardiovascular outcomes.In this paper,we will review the associations between OSA and cardiovascular diseases in women.The data on sex differences is limited,due to a number of reasons,including,but not limited to late presentation of OSA in women,diffi culties in diagnosing both OSA and cardiovascular diseases in women and still suboptimal inclusion of adequate number of women in clinical trials.More studies are needed to better delineate sex differences in the clinical presentation as well as the pathophysiology of the associations between OSA and cardiovascular diseases so that we can provide patients with more personalized care.Nimeh Najjar,MD Peter Staiano,MD Mariam Louis,MD,MSc,FCCP 2019Cardiovascular Innovations and Applications2019,,B02:1
10Dyspnea Is a Better Predictor of 5 - Year Survival Than Airway Obstruction in Patient With COPD 显示文摘Koichi Nishimura MD Takateru Izumi MD FCCP Mitsuhiro Tsuki- no kiD 2002Chest2002,121,5:1
11Improvement in Resting lnspira- tory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes显示文摘Celli B FCCP M Wallack RZ 2003Chest2003,124,:1
12A Pathogenic Triad in Chronic Cough显示文摘Brumo Carlos Palombini MD PhD FCCP 1999Chest1999,116,:1
13Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction显示文摘RODOLFO C MORICE FCCP TURHAN ECE FERAH ECE 2001Chest2001,119,:1
14Detection and localizationof intraepithelial neoplasia and invasive carcinoma using fluorescence-re- flectance bronchoscopy 显示文摘Eric Edell MD stephen Lam MD FCCP 2009AM J Thorac Onco12009,4,1:1
15Macrolides for the Treatment of Chronic Sinusitis,Asthma,and COPD显示文摘Mark H Gotfried MD FCCP 2004Chest2004,125,2:1
16Body fat distribution and sleep apnea severity in women显示文摘MILLMAN R P FCCP M D CARLISLE C C 1995Chest1995,107,:1
17Immunomodulatory activity and effectiveness of macrolides in chronicairway disease 显示文摘Bruce K Rubin Mengr MD FCCP Markus O Henke MD 2004CHEST2004,125,:1
18Antithrombotic therapy for non ST-segment elevation acute coronary syndromes:American College of Physicians evidence based clinical practice guidelines(8th Edition)显示文摘Robert A Harrington FCCP Richard C 2008Chest2008,133,:1
19Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation SPORTIF Ⅱ :A dose-guiding tolerability and safety study显示文摘Palle Petersen DMSc FCCP 2003J Am Coll Cardio2003,41,:1
20Carcinoma Arising from an Epiphrenic Diverticulum:A Frequently Misdiagnosed Disease显示文摘Szu-Tsen Lai Chung-Ping Hsu FCCP 2007Ann Thorac Cardiovasc Surg2007,13,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费